Kluwer Patent Cases

Case Law, evidence, Infringement, Injunction, Kluwer Patent Cases, Legislation, Litigation, Patents, Pharma, Pharmaceutical patent, United Kingdom

, (Bristows)/ /1 Comment

On Friday 13 March 2020, Birss J handed down a pair of judgments in the litigation between Evalve (a member of the Abbott group of companies) and Edwards Lifesciences, a veteran of UK patent litigation over the past decade. In the first judgment Evalve’s two UK patents, EP (UK) 1 408 850 and EP (UK)…

Case Law, Equivalents, Infringement, Inventive step, Kluwer Patent Cases, Litigation, Patents, Prior art, Prior use right, Revocation, United Kingdom, Validity

(Bristows)/ /2 Comments

A further interesting decision handed down by the Judges of the English Patents Court prior to the Easter break was a judgment from Nugee J concerning proceedings between E. Mishan and Hozelock relating to a UK patent and European patent, both entitled “Expandable Hose Assembly”. E. Mishan (trading as Emson) claimed that Hozelock’s expandable garden…

Inventive step, Kluwer Patent Cases, Pharmaceutical patent, Prior art, United Kingdom, Validity

(Bristows)/

Last year, Actavis, Teva and Mylan (“Actavis”) sought revocation in the English Patents Court of two patents relating to tadalafil, which is sold by Eli Lilly (“Lilly”) as the active ingredient in CIALIS® to treat erectile dysfunction and pulmonary arterial hypertension. As is the usual course, ICOS (the patentee) and Lilly (the exclusive licensee) subsequently…

(Indirect) infringement, Enforcement, Finland, Kluwer Patent Cases, Pharma, TRIPS

(Roschier)/

The Finnish Supreme Court held that the reversal of the burden of proof stipulated in Article 34 TRIPs as implemented in the Finnish Patent Act does not per se require a party to disclose its manufacturing process, but only to prove that it used a different process than that specified in the patent. The threshold…

Added matter, Amendments, EPC, Extension of subject matter, Germany, Kluwer Patent Cases, Mechanical Engineering, Revocation, Validity

(Hoffmann Eitle)/

The judgement “Schleifprodukt” rendered by the German Federal Court of Justice on 25 November 2014 could be seen as a step towards harmonisation with the EPO because the court carried out the test for the admissibility of claim amendments by assessing whether the feature combination of the amended claim in its entirety represents a technical teaching which is identifiable from the original application as being suitable for achieving the effects of the invention.

Case Law, EPC, EPO Decision, Kluwer Patent Cases

/

The Board of Appeal rejected an attempt to apply the fiction of novelty of “medical” substances and compositions of article 54(5) EPC to a dialysis membrane. Contrary to T2003/08 the claimed dialysis membrane did not contain any further substance that might constitute an active ingredient. With reference to arguments in T2003/08, the board noted that…

Bulgaria, Case Law, Kluwer Patent Cases

(Delchev & Partners)/

The Bulgarian Patent Office refused to issue a supplementary protection certificate for a medical product comprising three components as one of them was not within the scope of protection of the basic patent. The decision of the Patent Office was first annulled by the first instance court but subsequently upheld by the Bulgarian Supreme Administrative Court….

Case Law, EPC, EPO Decision, Inventive step, Kluwer Patent Cases

/

The Board emphasized that there was a relation between who was to be considered to be the skilled person for judging inventive step on one hand and the choice of the closest prior art on the other hand. A general problem to modify a product from one field so that it could be used in…

Biologics, Case Law, EPC, EPO Decision, Kluwer Patent Cases

/

Inventions regarding a method of improving the yield of triploid seedless watermelons by pollination with a specific type of diploid water melon are not to be regarded as an essentially biological process for the production of plants and are therefore not excluded from patentability under Article 53(b) EPC. These biotechnological inventions according to Rule 26(2),…

Case Law, Kluwer Patent Cases, Netherlands

(Brinkhof)/

Direct access to seized documents, selected from a larger pool of previously seized evidence, is denied on the basis of Dutch procedural provisions relating to Directive 2004/48/EC, because the defendant has not been allowed prior review of the seized selection. The court only allows access to a limited selection obtained by sufficient specific key word…